Interventional Ketamine Therapy represents a significant advancement in the treatment of mental health conditions. Unlike traditional antidepressants, which focus on serotonin or norepinephrine, Ketamine targets the glutamate system—the brain’s most abundant chemical messenger. This approach facilitates the rapid growth of new neural connections, offering hope and relief for those who have not found success with standard therapies.Conditions Treated:
Our interventional psychiatry services provide relief for a variety of treatment-resistant conditions, including Treatment-Resistant Depression (TRD), Major Depressive Disorder with Suicidal Ideation, Bipolar Depression, PTSD, and Severe Anxiety Disorders.Treatment Options:
We provide multiple administration methods to ensure the most effective delivery for each patient’s unique needs:
Spravato (Esketamine): An FDA-approved nasal spray administered under medical supervision, specifically for treatment-resistant depression and major depressive disorder with suicidal ideation.What to Expect:
Your journey begins with a comprehensive psychiatric consultation to determine the most effective treatment path for you. During administration sessions, you will be in a comfortable, private setting under continuous medical supervision. Most patients experience a rapid reduction in symptoms within a few sessions, and our team is dedicated to providing a safe, supportive, and professional environment throughout your entire treatment and recovery process.
IV Ketamine Infusion: A 40-minute infusion in a private room, monitored by psychiatric staff for optimal safety and comfort.
Our clinic is located in Fairfax, VA, and we are proud to serve patients across the Washington D.C., Maryland, and Virginia (DMV) region.
Clinical Leadership & Safety
Our clinic is led by board-certified psychiatrists Dr. Partam Manalai MD and Dr. Mohammad Ayan Ghairatmal MD. Our commitment to safety is paramount; we strictly enforce clinical safety boundaries, which include no at-home ketamine treatments and the requirement of a mandatory private driver (no rideshare) for post-treatment transport. Furthermore, our philanthropic mission involves reinvesting profits back into medical education to support the next generation of providers.